TAVR replacement of Stenotic Aortic Valve with ACURATE Neo2 Valve.

Trial ID:

IRB-19-7448

Paul S. Teirstein, M.D., FACC

The study will compare the safety and effectiveness of the investigational ACURATE Valve, compared to other commercially available TAVR devices (Control Valves).

*Have diagnosed severe symptomatic native aortic stenosis. <br>*Have NYHA Functional Class = II.<br>*Be capable and willing to return to the study hospital for all required scheduled follow up visits.<br>*Be able to take the protocol-required medications<br><br>

Contact Info:

• CRS Leadership
• CRSLeadership@scrippshealth.org